Compounds > melatonin

melatonin and rifampin

melatonin has been researched along with rifampin in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Boeddrich, A; Heiser, V; Lehrach, H; Lurz, R; Nordhoff, E; Scherzinger, E; Schugardt, N; Wanker, EE1
Melchor, JP; Van Nostrand, WE1
Loots, DT; Mienie, LJ; Page, BJ; van Helden, PD; Wiid, IJ1
Amero, C; French-Pacheco, L; Maya-Martinez, R; Pastor, N; Pelaez-Aguilar, AE; Rivillas-Acevedo, L; Valdes-Garcia, G1

Other Studies

8 other study(ies) available for melatonin and rifampin

ArticleYear
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy.
    Proceedings of the National Academy of Sciences of the United States of America, 2000, Jun-06, Volume: 97, Issue:12

    Topics: Animals; Antibodies, Monoclonal; Benzoates; Benzothiazoles; Biphenyl Compounds; Congo Red; COS Cells; Gossypol; Humans; Huntingtin Protein; Huntington Disease; Melatonin; Nerve Tissue Proteins; Nuclear Proteins; Peptides; Rifampin; Thiazoles

2000
Disruption of pathologic amyloid beta-protein fibril assembly on the surface of cultured human cerebrovascular smooth muscle cells.
    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2001, Volume: 8 Suppl 1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Cell Membrane; Cells, Cultured; Cerebral Amyloid Angiopathy; Humans; Inositol; Macromolecular Substances; Melatonin; Microscopy, Electron; Muscle, Smooth, Vascular; Rifampin; Rolitetracycline

2001
Melatonin prevents the free radical and MADD metabolic profiles induced by antituberculosis drugs in an animal model.
    Journal of pineal research, 2005, Volume: 38, Issue:2

    Topics: Animals; Antioxidants; Antitubercular Agents; Carboxylic Acids; Death Domain Receptor Signaling Adaptor Proteins; Drug Combinations; Free Radicals; Guanine Nucleotide Exchange Factors; Hydroxybenzoates; Isoniazid; Melatonin; Oxidative Stress; Pyrazinamide; Rats; Rats, Sprague-Dawley; Rifampin

2005
Inhibition of Light Chain 6aJL2-R24G Amyloid Fiber Formation Associated with Light Chain Amyloidosis.
    Biochemistry, 2015, Aug-18, Volume: 54, Issue:32

    Topics: Amino Acid Sequence; Amino Acid Substitution; Amyloid; Amyloidosis; Catechin; Humans; Immunoglobulin Light Chains; In Vitro Techniques; Melatonin; Microscopy, Electron, Transmission; Models, Molecular; Molecular Sequence Data; Mutation, Missense; Nuclear Magnetic Resonance, Biomolecular; Protein Binding; Protein Multimerization; Quercetin; Recombinant Proteins; Rifampin; Tetracycline

2015